These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The Potential of Combination Therapeutics for More Complete Repair of Volumetric Muscle Loss Injuries: The Role of Exogenous Growth Factors and/or Progenitor Cells in Implantable Skeletal Muscle Tissue Engineering Technologies. Passipieri JA; Christ GJ Cells Tissues Organs; 2016; 202(3-4):202-213. PubMed ID: 27825153 [TBL] [Abstract][Full Text] [Related]
8. An acellular biologic scaffold does not regenerate appreciable de novo muscle tissue in rat models of volumetric muscle loss injury. Aurora A; Roe JL; Corona BT; Walters TJ Biomaterials; 2015 Oct; 67():393-407. PubMed ID: 26256250 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological Mitigation of Fibrosis in a Porcine Model of Volumetric Muscle Loss Injury. Corona BT; Rivera JC; Dalske KA; Wenke JC; Greising SM Tissue Eng Part A; 2020 Jun; 26(11-12):636-646. PubMed ID: 31856683 [TBL] [Abstract][Full Text] [Related]
10. Maresin 1 repletion improves muscle regeneration after volumetric muscle loss. Castor-Macias JA; Larouche JA; Wallace EC; Spence BD; Eames A; Duran P; Yang BA; Fraczek PM; Davis CA; Brooks SV; Maddipati KR; Markworth JF; Aguilar CA Elife; 2023 Dec; 12():. PubMed ID: 38131691 [TBL] [Abstract][Full Text] [Related]
11. Laminin-111-Enriched Fibrin Hydrogels Enhance Functional Muscle Regeneration Following Trauma. Ziemkiewicz N; Hilliard GM; Dunn AJ; Madsen J; Haas G; Au J; Genovese PC; Chauvin HM; West C; Paoli A; Garg K Tissue Eng Part A; 2022 Apr; 28(7-8):297-311. PubMed ID: 34409846 [TBL] [Abstract][Full Text] [Related]
12. Identifying dysregulated immune cell subsets following volumetric muscle loss with pseudo-time trajectories. Hymel LA; Anderson SE; Turner TC; York WY; Zhang H; Liversage AR; Lim HS; Qiu P; Mortensen LJ; Jang YC; Willett NJ; Botchwey EA Commun Biol; 2023 Jul; 6(1):749. PubMed ID: 37468760 [TBL] [Abstract][Full Text] [Related]
13. Photoreactive Hydrogel Stiffness Influences Volumetric Muscle Loss Repair. Basurto IM; Passipieri JA; Gardner GM; Smith KK; Amacher AR; Hansrisuk AI; Christ GJ; Caliari SR Tissue Eng Part A; 2022 Apr; 28(7-8):312-329. PubMed ID: 34409861 [TBL] [Abstract][Full Text] [Related]
14. Restricted physical activity after volumetric muscle loss alters whole-body and local muscle metabolism. Raymond-Pope CJ; Basten AM; Bruzina AS; McFaline-Figueroa J; Lillquist TJ; Call JA; Greising SM J Physiol; 2023 Feb; 601(4):743-761. PubMed ID: 36536512 [TBL] [Abstract][Full Text] [Related]
15. Acellular collagen-glycosaminoglycan matrix promotes functional recovery in a rat model of volumetric muscle loss. Zhu C; Karvar M; Koh DJ; Sklyar K; Endo Y; Quint J; Samandari M; Tamayol A; Sinha I Regen Med; 2023 Aug; 18(8):623-633. PubMed ID: 37491948 [TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical Agents for Contractile-Metabolic Dysfunction After Volumetric Muscle Loss. McFaline-Figueroa J; Schifino AG; Nichenko AS; Lord MN; Hunda ET; Winders EA; Noble EE; Greising SM; Call JA Tissue Eng Part A; 2022 Sep; 28(17-18):795-806. PubMed ID: 35620911 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic Approaches for Volumetric Muscle Loss Injury: A Systematic Review and Meta-Analysis. Greising SM; Corona BT; McGann C; Frankum JK; Warren GL Tissue Eng Part B Rev; 2019 Dec; 25(6):510-525. PubMed ID: 31578930 [TBL] [Abstract][Full Text] [Related]